Kadmon, a Sanofi Company, is a biopharmaceutical company that discovers, develops and markets transformative therapies for unmet medical needs. Our team has a proven track record of successful drug development and commercialization. Our clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.
Our late-stage product candidate, belumosudil, is an orally administered selective inhibitor of Rho-associated coiled-coil kinase 2 (ROCK2) in development for the treatment of inflammatory and fibrotic diseases. A pivotal study of belumosudil is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 study in systemic sclerosis.
Kadmon is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. Our lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein in a Phase 1 clinical trial.
Comments are no longer monitored.
Company Details
- Employees
- 45
- Address
- 450 East 29th Street, New York,ny 10016,united States
- Phone
- 2126832105
- da****@****ers.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- kadmon.com
- Keywords
- Coordinator jobs.
- HQ
- New York, NY
Kadmon, A Sanofi Company Questions
Kadmon, A Sanofi Company's helpline number is 2126832105
Kadmon, A Sanofi Company's website is kadmon.com
Kadmon, A Sanofi Company's LinkedIn profile is https://www.linkedin.com/company/kadmon-corporation-llc
Kadmon, A Sanofi Company has
45 employees.
View email and phone details for 45
employees at Kadmon, A Sanofi Company.
Kadmon, A Sanofi Company's industry is
Biotechnology Research
Kadmon, A Sanofi Company's top competitors are
Roche,
Novartis,
Astrazeneca,
Pfizer,
Medley,
Sanofi Pasteur Msd,
Johnson & Johnson,
Sanofi,
Bayer,
Gsk.
Kadmon, A Sanofi Company's support email address is david@argotpartners.com
Kadmon, A Sanofi Company's categories are Biotechnology Research
